Bristol-Myers Squibb BMY Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Bristol-Myers Squibb in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Bristol-Myers Squibb’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bristol-Myers Squibb's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bristol-Myers Squibb's deferred taxes?
- Bristol-Myers Squibb (BMY) reported deferred taxes of $211M in Q1 2026.
- How has Bristol-Myers Squibb's deferred taxes changed year-over-year?
- Bristol-Myers Squibb's deferred taxes decreased by 23.6% year-over-year, from $276M to $211M.
- What is the long-term trend for Bristol-Myers Squibb's deferred taxes?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's deferred taxes has grown at a -47.2% compound annual growth rate (CAGR), from $5.41B to $222M.
- What does deferred taxes mean?
- Future tax payments resulting from timing differences between accounting and tax reporting.
- How do you interpret deferred taxes?
- An increase indicates that the company has deferred tax payments to the future, which can be a source of temporary cash flow benefit.
- How does deferred taxes compare across companies?
- Common in capital-intensive firms where tax depreciation schedules differ from financial reporting depreciation.